Indias Net FDI Rises in FY26 on Stronger Gross Inflows While Portfolio Investment Weakens IIT Madras and IIT Kanpur to Support CBSE in Resolving Revaluation Portal Technical Issues Grenfell Tower Prosecutions Charges Recommended Against 77 Individuals and Organisations After NineYear Investigation Dismissal of Criminal Case in Wrongful Deportation May Highlight Political Risk Factors Prediction Markets Surge as Young Male Traders Drive MultiBillion Dollar Growth EU Industrial Sovereignty at Risk Five Sectors Critically Dependent on China Tenaris TS Q1 2026 Earnings EPS Beat Drives Upbeat Outlook Yet Shares Slip VZ Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Operational Stability Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed GCBC Q2 2025 Earnings Solid EPS of 044 Despite Absence of Consensus Estimates DDOG Q1 2026 Earnings EPS Surprise of 1585 Fuels Modest Gains FOXA Q1 2026 Earnings EPS Surges Past Estimates with 339 Beat First Guaranty Bancshares Preferred FGBIP Edges Lower as Consolidation Continues Hovnanian Enterprises HOV Dips 295 as Homebuilder Sentiment Falters Cigna Group CI Holds Steady Near Support as Healthcare Sector Shows Resilience Enterprise Financial Services Series A Preferred EFSCP Faces Mild Pullback as Yields Adjust PIMCO Dynamic Income Fund PDI Holds Steady Near 1667 with Support and Resistance in Focus Este Lauder Ends Merger Talks with Spanish Rival Puig Over Compensation Sticking Point XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue mF International Limited MFI Plunges 1067 Key Support Levels in Focus nLIGHT Inc LASR Rallies 209 to 7803 Testing Key Resistance Levels RPC Inc RES Faces Continued Pressure as Shares Test Key Support Levels DBV Technologies DBVT Edges Higher Amid Sector Positioning Key Levels in Focus Xeris Biopharma XERS Drops 298 Testing Key Support Near 588 American International Group AIG Stock Declines 249 Testing Key Support Levels Blaize Holdings Warrants BZAIW Edge Higher Following Support Bounce Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344